Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice
Interindividual variability in drug efficacy and toxicity is a major challenge in clinical practice. Variations in drug pharmacokinetics (PKs) and pharmacodynamics (PDs) can be, in part, explained by polymorphic variants in genes encoding drug metabolizing enzymes and transporters (absorption, distr...
Saved in:
Main Authors: | Mariamena Arbitrio (Author), Francesca Scionti (Author), Maria Teresa Di Martino (Author), Daniele Caracciolo (Author), Licia Pensabene (Author), Pierfrancesco Tassone (Author), Pierosandro Tagliaferri (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose-Finding Study and Pharmacokinetics Profile of the Novel 13-Mer Antisense miR-221 Inhibitor in Sprague-Dawley Rats
by: Maria Teresa Di Martino, et al.
Published: (2020) -
Scaling approaches for the prediction of human clearance of LNA-i-mir-221: A retrospective validation
by: Massimiliano Fonsi, et al.
Published: (2024) -
BRCA1/2 genetic background-based therapeutic tailoring of human ovarian cancer: hope or reality?
by: Tagliaferri Pierosandro, et al.
Published: (2009) -
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review
by: Maria Teresa Di Martino, et al.
Published: (2022) -
Pharmacokinetics and Pharmacodynamics of a 13-mer LNA-inhibitor-miR-221 in Mice and Non-human Primates
by: Maria Eugenia Gallo Cantafio, et al.
Published: (2016)